Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

OSILODROSTAT vs OSPEMIFENE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

OSILODROSTAT vs OSPEMIFENE: Safety Overview

Metric OSILODROSTAT OSPEMIFENE
Total FAERS Reports 1,626 2,047
Deaths Reported 191 2
Death Rate 11.7% 0.1%
Hospitalizations 526 60
Average Patient Age 56.3 yrs 61.7 yrs
% Female Patients 70.8% 99.8%
FDA Approval Date Mar 6, 2020 Feb 13, 2024
Manufacturer Recordati Rare Diseases, Inc. Duchesnay USA, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription